Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daming Gao

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Cell Research|March 11, 2015
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancerShunrong Ji, Yi Qin, Si Shi, et al.
The Journal of Clinical Investigation|July 4, 2024
CDKL3 is a targetable regulator of cell cycle progression in cancersHaijiao Zhang, Jiahui Lin, Shaoqin Zheng, et al.
Cell|June 25, 2024
Pan-cancer proteogenomics expands the landscape of therapeutic targetsSara R Savage, Xinpei Yi, Jonathan T Lei, et al.
Molecular Cell|October 25, 2011
mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTORDaming Gao, Hiroyuki Inuzuka, Meng-Kwang Marcus Tan, et al.
Cancer Cell|August 17, 2010
Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligaseHiroyuki Inuzuka, Alan Tseng, Daming Gao, et al.
Acta Neuropathologica Communications|September 24, 2025
RNF168 dephosphorylation ameliorates cognitive decline in Aβ-based mouse models of Alzheimer's diseaseMiao-Jin Ji, Yun Li, Jiao Yang, et al.
Cell Reports. Medicine|December 5, 2023
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinomaJianchun Duan, Yun Zhang, Ran Chen, et al.
Journal for Immunotherapy of Cancer|July 21, 2022
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilitiesJian Lin, Yuting Dai, Chen Sang, et al.
Cell Reports|June 29, 2023
Identification of XAF1 as an endogenous AKT inhibitorMin Chen, Kangjunjie Wang, Ying Han, et al.
Cancer Discovery|July 24, 2023
An Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS-Mutant Intrahepatic CholangiocarcinomaMao Zhang, Yingying Huang, Jiaomeng Pan, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Cell Research|March 11, 2015
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancerShunrong Ji, Yi Qin, Si Shi, et al.
The Journal of Clinical Investigation|July 4, 2024
CDKL3 is a targetable regulator of cell cycle progression in cancersHaijiao Zhang, Jiahui Lin, Shaoqin Zheng, et al.
Cell|June 25, 2024
Pan-cancer proteogenomics expands the landscape of therapeutic targetsSara R Savage, Xinpei Yi, Jonathan T Lei, et al.
Molecular Cell|October 25, 2011
mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTORDaming Gao, Hiroyuki Inuzuka, Meng-Kwang Marcus Tan, et al.
Cancer Cell|August 17, 2010
Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligaseHiroyuki Inuzuka, Alan Tseng, Daming Gao, et al.
Acta Neuropathologica Communications|September 24, 2025
RNF168 dephosphorylation ameliorates cognitive decline in Aβ-based mouse models of Alzheimer's diseaseMiao-Jin Ji, Yun Li, Jiao Yang, et al.
Cell Reports. Medicine|December 5, 2023
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinomaJianchun Duan, Yun Zhang, Ran Chen, et al.
Journal for Immunotherapy of Cancer|July 21, 2022
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilitiesJian Lin, Yuting Dai, Chen Sang, et al.
Cell Reports|June 29, 2023
Identification of XAF1 as an endogenous AKT inhibitorMin Chen, Kangjunjie Wang, Ying Han, et al.
Cancer Discovery|July 24, 2023
An Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS-Mutant Intrahepatic CholangiocarcinomaMao Zhang, Yingying Huang, Jiaomeng Pan, et al.
Pageof 12